440 related articles for article (PubMed ID: 18847400)
1. Potential of old-generation antibiotics to address current need for new antibiotics.
Falagas ME; Grammatikos AP; Michalopoulos A
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):593-600. PubMed ID: 18847400
[TBL] [Abstract][Full Text] [Related]
2. Old antibiotics for infections in critically ill patients.
Falagas ME; Kopterides P
Curr Opin Crit Care; 2007 Oct; 13(5):592-7. PubMed ID: 17762241
[TBL] [Abstract][Full Text] [Related]
3. [Side effects of antibiotic therapy (review of the literature)].
Solov'ev VN; Berezhinskaia VV
Vopr Okhr Materin Det; 1974 Sep; 19(9):63-9. PubMed ID: 4370853
[No Abstract] [Full Text] [Related]
4. [Miscellaneous antibiotics].
Sawae Y
Nihon Rinsho; 1990 Oct; 48(10):2200-4. PubMed ID: 2280465
[No Abstract] [Full Text] [Related]
5. Do we still need the aminoglycosides?
Durante-Mangoni E; Grammatikos A; Utili R; Falagas ME
Int J Antimicrob Agents; 2009 Mar; 33(3):201-5. PubMed ID: 18976888
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.
Roussos N; Karageorgopoulos DE; Samonis G; Falagas ME
Int J Antimicrob Agents; 2009 Dec; 34(6):506-15. PubMed ID: 19828298
[TBL] [Abstract][Full Text] [Related]
7. Fusidic acid: new opportunities with an old antibiotic.
Anderson JD
Can Med Assoc J; 1980 Apr; 122(7):765-9. PubMed ID: 6988070
[TBL] [Abstract][Full Text] [Related]
8. [Revival of selected well-tried antibiotics. Special features of the antiinfective agents penicillin G, fosfomycin, aztreonam and colistin].
Lipp HP
Med Monatsschr Pharm; 2012 Oct; 35(10):367-77. PubMed ID: 23094579
[TBL] [Abstract][Full Text] [Related]
9. Other antibiotics.
Hayashi K
Clin Orthop Relat Res; 1984 Nov; (190):109-13. PubMed ID: 6386254
[TBL] [Abstract][Full Text] [Related]
10. Old and new targets of antibacterial therapy.
Dbaibo GS
J Med Liban; 2000; 48(4):177-81. PubMed ID: 11214186
[TBL] [Abstract][Full Text] [Related]
11. The tide of antimicrobial resistance and selection.
Wilcox MH
Int J Antimicrob Agents; 2009 Aug; 34 Suppl 3():S6-10. PubMed ID: 19596111
[TBL] [Abstract][Full Text] [Related]
12. What's new on the antimicrobial horizon?
Song JH
Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
[TBL] [Abstract][Full Text] [Related]
13. Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.
Hainrichson M; Nudelman I; Baasov T
Org Biomol Chem; 2008 Jan; 6(2):227-39. PubMed ID: 18174989
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotics].
Ono Y
Nihon Rinsho; 2012 Aug; 70 Suppl 6():131-9. PubMed ID: 23156498
[No Abstract] [Full Text] [Related]
15. [Aminoglycosides and polymyxins].
Molina J; Cordero E; Palomino J; Pachón J
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):178-88. PubMed ID: 19303668
[TBL] [Abstract][Full Text] [Related]
16. [Colimycin: an old antibiotic which has to be learnt to know].
Cohen R
Arch Pediatr; 2010 Sep; 17 Suppl 4():S171-6. PubMed ID: 20826327
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic use: present and future.
Zinner SH
New Microbiol; 2007 Jul; 30(3):321-5. PubMed ID: 17802919
[TBL] [Abstract][Full Text] [Related]
18. [The revival of colistin: an old antibiotic for the 21st century].
Nasnas R; Saliba G; Hallak P
Pathol Biol (Paris); 2009 May; 57(3):229-35. PubMed ID: 18178335
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycoside therapy in infectious diseases.
Poulikakos P; Falagas ME
Expert Opin Pharmacother; 2013 Aug; 14(12):1585-97. PubMed ID: 23746121
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance: mechanisms and strategies.
Woods CR
Paediatr Respir Rev; 2006; 7 Suppl 1():S128-9. PubMed ID: 16798537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
